Shelton Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,858
Closed -$218K 771
2022
Q1
$218K Buy
+2,858
New +$218K 0.01% 722
2021
Q2
Sell
-2,858
Closed -$200K 848
2021
Q1
$200K Buy
+2,858
New +$200K 0.01% 780